Stratifying Indeterminate Cytology Thyroid Nodules by Combining Thyroid Imaging Reporting and Data Systems (TI-RADS) and The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC)

Objective: To determine the risk of malignancy of Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) indeterminate Thyroid  Nodules (Bethesda III, IV and V) by combining cytologic (TSBRTC) and Thyroid Imaging Reporting and Data Systems (TI-RADS) ultrasonographic features based on final hi...

Full description

Bibliographic Details
Main Authors: Steve Marlo Cambe, Joseph Anthony Arañas, Jamie Lynne Manzana, Katleya Teresa Manlapaz
Format: Article
Language:English
Published: Philippine Society of Otolaryngology-Head and Neck Surgery, Inc. 2023-11-01
Series:Philippine Journal of Otolaryngology Head and Neck Surgery
Subjects:
Online Access:https://pjohns.pso-hns.org/index.php/pjohns/article/view/1703
_version_ 1827634690507407360
author Steve Marlo Cambe
Joseph Anthony Arañas
Jamie Lynne Manzana
Katleya Teresa Manlapaz
author_facet Steve Marlo Cambe
Joseph Anthony Arañas
Jamie Lynne Manzana
Katleya Teresa Manlapaz
author_sort Steve Marlo Cambe
collection DOAJ
description Objective: To determine the risk of malignancy of Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) indeterminate Thyroid  Nodules (Bethesda III, IV and V) by combining cytologic (TSBRTC) and Thyroid Imaging Reporting and Data Systems (TI-RADS) ultrasonographic features based on final histopathology. Methods: Design: Retrospective review of records Setting: Tertiary Private Training Hospital Participants: 551 records Results: Among 81 eligible participants, 59 out of 84 nodules (70.24%) wer malignant on histopathology. The malignancy risk of Bethesda classification was 60.87% (28 out of 46) for Bethesda III, 57.14% (8 out of 14) for Bethesda IV and 95.83% for Bethesda V. The malignancy risk for TI-RADS categories was 0 % (0/1) for TI-RADS 2, 50% (10 out of 20) for TI-RADS 3, 71.05 % for TI-RADS 4 and 91.67 % for TI-RADS 5. The highest risk of malignancy (100%) was associated with [Bethesda IV/TI-RADS 1, 2, and 3], [Bethesda V/TI-RADS 1, 2 and 3 [Bethesda IV and V/TI-RADS 1, 2 and 3] and [Bethesda IV/TI-RADS 5]. The lowest risk of malignancy (33.33%) was associated with [Bethesda III/TI-RADS1, 2 and 3]. A high Bethesda classification (Bethesda V) was almost 5x more likely to have a malignant anatomorphology compared with Bethesda III (p = .05) while a TI-RADS 4 or 5 category was almost 5x more likely to have a malignant anatomorphology compared to TI-RADS 1, 2 or 3 (p = .026). Conclusion: This study showed that TI-RADS scoring is a sensitive diagnostic classification in recognizing patients with thyroid cancer and combining Bethesda classification and TI-RADS scoring increases the sensitivity in the diagnosis of malignant thyroid nodules. A higher likelihood of malignancy is associated with higher Bethesda classification and TI-RADS scoring.
first_indexed 2024-03-09T15:16:50Z
format Article
id doaj.art-ada28ca8683940618b4813625482b337
institution Directory Open Access Journal
issn 1908-4889
2094-1501
language English
last_indexed 2024-03-09T15:16:50Z
publishDate 2023-11-01
publisher Philippine Society of Otolaryngology-Head and Neck Surgery, Inc.
record_format Article
series Philippine Journal of Otolaryngology Head and Neck Surgery
spelling doaj.art-ada28ca8683940618b4813625482b3372023-11-26T13:02:00ZengPhilippine Society of Otolaryngology-Head and Neck Surgery, Inc.Philippine Journal of Otolaryngology Head and Neck Surgery1908-48892094-15012023-11-01382Stratifying Indeterminate Cytology Thyroid Nodules by Combining Thyroid Imaging Reporting and Data Systems (TI-RADS) and The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC)Steve Marlo Cambe0Joseph Anthony Arañas1Jamie Lynne Manzana2Katleya Teresa Manlapaz3St Lukes Medical CenterSt. Luke’s Medical CenterInstitute of Radiology, St. Luke’s Medical Center Institute of Radiology St. Luke’s Medical Center Objective: To determine the risk of malignancy of Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) indeterminate Thyroid  Nodules (Bethesda III, IV and V) by combining cytologic (TSBRTC) and Thyroid Imaging Reporting and Data Systems (TI-RADS) ultrasonographic features based on final histopathology. Methods: Design: Retrospective review of records Setting: Tertiary Private Training Hospital Participants: 551 records Results: Among 81 eligible participants, 59 out of 84 nodules (70.24%) wer malignant on histopathology. The malignancy risk of Bethesda classification was 60.87% (28 out of 46) for Bethesda III, 57.14% (8 out of 14) for Bethesda IV and 95.83% for Bethesda V. The malignancy risk for TI-RADS categories was 0 % (0/1) for TI-RADS 2, 50% (10 out of 20) for TI-RADS 3, 71.05 % for TI-RADS 4 and 91.67 % for TI-RADS 5. The highest risk of malignancy (100%) was associated with [Bethesda IV/TI-RADS 1, 2, and 3], [Bethesda V/TI-RADS 1, 2 and 3 [Bethesda IV and V/TI-RADS 1, 2 and 3] and [Bethesda IV/TI-RADS 5]. The lowest risk of malignancy (33.33%) was associated with [Bethesda III/TI-RADS1, 2 and 3]. A high Bethesda classification (Bethesda V) was almost 5x more likely to have a malignant anatomorphology compared with Bethesda III (p = .05) while a TI-RADS 4 or 5 category was almost 5x more likely to have a malignant anatomorphology compared to TI-RADS 1, 2 or 3 (p = .026). Conclusion: This study showed that TI-RADS scoring is a sensitive diagnostic classification in recognizing patients with thyroid cancer and combining Bethesda classification and TI-RADS scoring increases the sensitivity in the diagnosis of malignant thyroid nodules. A higher likelihood of malignancy is associated with higher Bethesda classification and TI-RADS scoring. https://pjohns.pso-hns.org/index.php/pjohns/article/view/1703Cytologically Indeterminate Thyroid noduleACR TIRADSBethesda Classificationthyroid malignancythyroid ultrasonographyUltrasound Guided- Fine Needle aspiration biopsy
spellingShingle Steve Marlo Cambe
Joseph Anthony Arañas
Jamie Lynne Manzana
Katleya Teresa Manlapaz
Stratifying Indeterminate Cytology Thyroid Nodules by Combining Thyroid Imaging Reporting and Data Systems (TI-RADS) and The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC)
Philippine Journal of Otolaryngology Head and Neck Surgery
Cytologically Indeterminate Thyroid nodule
ACR TIRADS
Bethesda Classification
thyroid malignancy
thyroid ultrasonography
Ultrasound Guided- Fine Needle aspiration biopsy
title Stratifying Indeterminate Cytology Thyroid Nodules by Combining Thyroid Imaging Reporting and Data Systems (TI-RADS) and The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC)
title_full Stratifying Indeterminate Cytology Thyroid Nodules by Combining Thyroid Imaging Reporting and Data Systems (TI-RADS) and The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC)
title_fullStr Stratifying Indeterminate Cytology Thyroid Nodules by Combining Thyroid Imaging Reporting and Data Systems (TI-RADS) and The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC)
title_full_unstemmed Stratifying Indeterminate Cytology Thyroid Nodules by Combining Thyroid Imaging Reporting and Data Systems (TI-RADS) and The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC)
title_short Stratifying Indeterminate Cytology Thyroid Nodules by Combining Thyroid Imaging Reporting and Data Systems (TI-RADS) and The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC)
title_sort stratifying indeterminate cytology thyroid nodules by combining thyroid imaging reporting and data systems ti rads and the bethesda system for reporting thyroid cytopathology tbsrtc
topic Cytologically Indeterminate Thyroid nodule
ACR TIRADS
Bethesda Classification
thyroid malignancy
thyroid ultrasonography
Ultrasound Guided- Fine Needle aspiration biopsy
url https://pjohns.pso-hns.org/index.php/pjohns/article/view/1703
work_keys_str_mv AT stevemarlocambe stratifyingindeterminatecytologythyroidnodulesbycombiningthyroidimagingreportinganddatasystemstiradsandthebethesdasystemforreportingthyroidcytopathologytbsrtc
AT josephanthonyaranas stratifyingindeterminatecytologythyroidnodulesbycombiningthyroidimagingreportinganddatasystemstiradsandthebethesdasystemforreportingthyroidcytopathologytbsrtc
AT jamielynnemanzana stratifyingindeterminatecytologythyroidnodulesbycombiningthyroidimagingreportinganddatasystemstiradsandthebethesdasystemforreportingthyroidcytopathologytbsrtc
AT katleyateresamanlapaz stratifyingindeterminatecytologythyroidnodulesbycombiningthyroidimagingreportinganddatasystemstiradsandthebethesdasystemforreportingthyroidcytopathologytbsrtc